4,282
Views
47
CrossRef citations to date
0
Altmetric
Research Article

Preparation of poly-l-lysine-based nanoparticles with pH-sensitive release of curcumin for targeted imaging and therapy of liver cancer in vitro and in vivo

, , , &
Pages 950-960 | Received 25 Feb 2018, Accepted 03 Apr 2018, Published online: 16 Apr 2018

References

  • Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. (2007). Bioavailability of curcumin: problems and promises. Mol Pharm 4:807–18.
  • Blau S, Jubeh TT, Haupt SM, et al. (2000). Drug targeting by surface cationization. Crit Rev Ther Drug Carrier Syst 17:425–65.
  • De Jaeghere F, Allemann E, Feijen JKT, et al. (2000). Cellular uptake of PEG surface-modified nanoparticles: evaluation of nanoparticles made of PLA:PEO diblock and triblock copolymers. J Drug Target 8:143–53.
  • Dhillon N, Aggarwal BB, Newman RA, et al. (2008). Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14:4491–9.
  • Faustino C, Serafim C, Rijo P, Reis CP. (2016). Bile acids and bile acid derivatives: use in drug delivery systems and as therapeutic agents. Expert Opin Drug Deliv 13:1133–48.
  • Gao W, Chan J, Farokhzad OC. (2010). pH-Responsive nanoparticles for drug delivery. Mol Pharm 7:1913–1920.
  • Gou M, Men K, Shi H, et al. (2011). Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale 3:1558–67.
  • Gref RMY, Peracchia MT, Trubetskoy V, et al. (1994). Biodegradable long-circulating polymeric nanospheres. Science 263:1600–3.
  • Hayden SC, Zhao G, Saha K, et al. (2012). Aggregation and interaction of cationic nanoparticles on bacterial surfaces. J Am Chem Soc 134:6920–3.
  • Hu C, Chen Z, Wu S, et al. (2017). Micelle or polymersome formation by PCL-PEG-PCL copolymers as drug delivery systems. Chin Chem Lett 28:1905–9.
  • Jain KK. 2008. Drug delivery systems – an overview. In: Jain KK, ed. Drug delivery system. Basel, Switzerland: Humana Press, 1–51.
  • Jin H, Pi J, Jiang J, et al. (2017). EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy. Nanoscale 9:16365–74.
  • Kuishima M, Kitao A, Kawachi C, et al. (2002). A racemization test in peptide synthesis using 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMT-MM). Chem Pharm Bull 50:549–50.
  • Kumari P, Muddineti OS, Rompicharla SVK, et al. (2017). Cholesterol-conjugated poly(D,L-lactide)-based micelles as a nanocarrier system for effective delivery of curcumin in cancer therapy. Drug Deliv 24:209–23.
  • Lv L, Qiu K, Yu X, et al. (2016). Amphiphilic copolymeric micelles for doxorubicin and curcumin co-delivery to reverse multidrug resistance in breast cancer. J Biomed Nanotechnol 12:973–85.
  • Mouslmani M, Rosenholm JM, Prabhakar N, et al. (2015). Curcumin associated poly(allyamine hydrochloride)-phosphate self-assembled hierarchically ordered nanocapsules: size dependent investigation on release and DPPH scavenging activity of curcumin. RSC Adv 5:18740–50.
  • Narvekar M, Xue HY, Eoh JY, Wong HL. (2014). Nanocarrier for poorly water-soluble anticancer drugs-barriers of translation and solutions. AAPS PharmSciTech 15:822–33.
  • Nguyen CT, Tran TH, Amiji M, et al. (2015). Redox-sensitive nanoparticles from amphiphilic cholesterol-based block copolymers for enhanced tumor intracellular release of doxorubicin. Nanomedicine 11:2071–82.
  • Park K, Lee S, Kang E, et al. (2009). New generation of multifunctional nanoparticles for cancer imaging and therapy. Adv Funct Mater 19:1553–66.
  • Park Y-J, Chang J, Chen P-C, Yang VC-M. (2001). Poly (L-lysine) based semi-interpenetrating polymer network as pH-responsive hydrogel for controlled release of a model protein drug streptokinase. Biotechnol Bioprocess Eng 6:326–31.
  • Patra D, leem F. (2013). A new method for pH triggered curcumin release by applying poly(L-lysine) mediated nanoparticle-congregation. Anal Chim Acta 795:60–8.
  • Peng JR, Qian ZY. (2014). Drug delivery systems for overcoming the bioavailability of curcumin: not only the nanoparticle matters. Nanomedicine (Lond) 9:747–50.
  • Sinha R, Kim GJ, Nie S, Shin DM. (2006). Nanotechnology in cancer therapeutics:an emerging treatment modality for cancer. Mol Cancer Ther 5:1909–17.
  • Tiwari A, Singh A, Garg N, Randhawa JK. (2017). Curcumin encapsulated zeolitic imidazolate frameworks as stimuli responsive drug delivery system and their interaction with biomimetic environment. Sci Rep 7:12598–609.
  • Trivedi R, Kompella UB. (2010). Nanomicellar formulations for sustained drug delivery: strategies and underlying principles. Nanomedicine (Lond) 5:485–505.
  • Vasir JK, Labhasetwar V. (2008). Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles. Biomaterials 29:4244–52.
  • Wang J, Qiang L, Yang L, et al. (2017). Curcumin-loaded TPGS/F127/P123 mixed polymeric micelles for cervical cancer therapy: formulation, characterization, and in vitro and in vivo evaluation. J Biomed Nanotechnol 13:1631–46.
  • Wang Z, Nui G, Chen X. (2014). Polymeric materials for theranostic applications. Pharm Res 31:1358–76.
  • Ward CM, Pechar M, Oupicky D, et al. (2001). Systemic circulation of polyL-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy. Blood 7:2221–9.
  • Wilhelm M, Zhao C-L, Wang Y, et al. (1991). Poly(styrene-ethylene oxide) block copolymer micelle formation in water: a fluorescence probe study. Macromolecules 24:1033–40.
  • Xu G, Liu S, Niu H, et al. (2014). Functionalized mesoporous carbon nanoparticles for targeted chemo-photothermal therapy of cancer cells under near-infrared irradiation. RSC Adv 4:33986–97.
  • Xu P, Van Kirk EA, Murdoch WJ., et al. (2006). Anticancer efficacies of cisplatin-releasing pH-responsive nanoparticles. Crit Rev Ther Drug Carrier Syst 7:829–35.
  • Yang DH, Kim HJ, Kim JK, et al. (2017). Preparation of redox-sensitive β-CD-based nanoparticles with controlled release of curcumin for improved therapeutic effect on liver cancer in vitro. J Ind Eng Chem 45:156–63.
  • Yang J, Gao C, Lü S, et al. (2014). Physicochemical characterization of amphiphilic nanoparticles based on the novel starch-deoxycholic acid conjugates and self-aggregates. Carbohy Polym 102:838–45.
  • Zhou Z, Tang Z, Sun WJ, et al. (2015). A multifunctional PEG-PLL drug conjugate forming redox-responsive nanoparticles for drug delivery. J Mater Chem B 3:7594–603.
  • Ziady AG, Ferkol T, Dawson DV, et al. (1999). Chain length of the polylysine in receptor-targeted gene transfer complexes affects duration of reporter gene expression both in vitro and in vivo. J Biol Chem 274:4908–16.